The neglected tropical diseases: The ancient afflictions of stigma and poverty and the prospects for their control and elimination

Advances in Experimental Medicine and Biology

Volumn 582, Issue , 2006, Pages 23-33

  Hotez, Peter ^a   Ottesen, Eric ^b   Fenwick, Alan ^c   Molyneux, David ^d  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b EMORY UNIVERSITY   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934441783     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/0-387-33026-7_3     Document Type: Review

References (37)

1. Bleakley, H. (2003). Disease and development: evidence from the American South. Journal of the European Economic Association. 1, 376-386.
2. Ceccarelli, G. (1994). Infettivologia e parasssitologia nella Bivvia. Minerva Medica. 85, 417-422.
3. Dirckx, J.H. (1985). The biblical plague of "hemorrhoids". An outbreak of bilharziasis. American Journal of Dermatopathology. 7, 31-36.
4. Ekwanzala, M., Pepin, J., Khonde, N., Molisho, S., Bruneel, H., and De Wals, P. (1996). In the heart of darkness: sleeping sickness in Zaire. Lancet. 348, 1427-1430.
5. Fenwick, A., Molyneux, D., Nantulya, V. (2005). Achieving the millennium development goals. Lancet. 365, 1029-1030.
6. Frick, K.D., Hanson, C.L., and Jacobson, G.A. (2003). Global burden of trachoma and economics of the disease. American Journal of Tropical Medicine and Hygiene. 69, 1-10.
7. Grove, D.I. (1990). A History of Human Helminthology. CAB International, pp. 209, 469, 521, and 616.
8. Harrison, G. (1978). Mosquitoes, Malaria & Man: A History of the Hostilities since 1880. New York: E.P. Dutton, pp. 242-54.
9. Hopkins, D.R., Ruiz-Tiben, E., Diallo, N., Withers, P.C. Jr., and Maguire, J.H. (2002). Drancunculiasis eradication: and now, Sudan. American Journal of Tropical Medicine and Hygiene. 67, 415-422.
10. Hotez, P.J. (2001). Vaccines as instruments of foreign policy. EMBO reports. 2, 862-868.
11. Hotez, P.J. (2004a). Should we establish a North American school of global health sciences? American Journal of Medical Sciences. 328, 71-77.
12. Hotez, P.J. (2004b). The National Institutes of Health roadmap and the developing world. Journal of Investigative Medicine. 52, 246-247.
13. Hotez, P.J., Brooker, S., Bethony, J.M., Bottazzi, M.E., Loukas, A., and Xiao, S.H. (2004a). Hookworm infection. New England Journal of Medicine. 351, 799-807.
14. Hotez, P.J., Remme, H., Buss, P., Alleyne, G., Morel, C., and Breman, J. (2004b). Combating tropical communicable diseases: workshop report of the disease control priorities project. Clinical Infectious Diseases. 38, 871-878.
15. Hotez, P.J., Bethony, J., Brooker, S., and Albonico, M. (2005). Eliminating neglected diseases in Africa. Lancet. 365, 2089.
16. Hulse, E.V. (1971). Joshua's curse and the abandonment of ancient Jericho: schistosomiasis as a possible medical explanation. Med. Hist. 15, 376-386.
17. King, C.H., Dickman, K., Tisch, D.J. (2005). Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet. 365, 1561-1569.
18. Kremer, M. and Glennerster. (2004). Strong Medicine, Creating Incentives for Pharmaceutical Research on Neglected Diseases. Princeton University Press. pp. 25-64.
19. Levine, R. and the What Works Working Group. (2004a). Millions Saved, Proven Successes in Global Health, Case 6, Controlling Onchocerciasis in Sub-Saharan Africa, Center for Global Development, pp. 57-64.
20. Levine, R. et al. (2004b). Millions Saved, Case 11, Controlling Chagas Disease in the Southern Cone of South America, pp. 99-104.
21. Little, M.P., Breitling, L.P., Basanez, M.G., Alley, E.S., and Boatin, B.A. (2004). Association between microfilarial load and excess mortality in onchocerciasis: an epidemiological study. Lancet. 363, 1514-1521.
22. Lockwood, D.N. and Suneetha, S. (2005). Leprosy: too complex a disease for a simple elimination paradigm. Bulletin of the World Health Organization. 83, 230-235.
23. Mecaskey, J.W., Knirsch, C.A., Kumaresan, J.A., and Cook, J.A. (2003). The possibility of eliminating blinding trachoma. Lancet. 3, 728-734.
24. Medecins Sans Frontieres. (2001). Fatal Imbalance, The Crisis in Research and Development for Drugs for Neglected Diseases. Medecins Sans Frontieres Access to Essential Medicines Campaign and the Drugs for Neglected Diseases Working Group, p. 12.
25. Molyneux, D.H. (1997). Patterns of change in vector-borne diseases. Annals of Tropical Medicine and Parasitology. 91, 827-839.
26. Molyneux, D.H. (2004). "Neglected" diseases but unrecognized successes - challenges and opportunities for infectious disease control. Lancet. 364, 380-383.
27. Molyneux, D.H. and Nantulya, V.M. (2004). Linking disease control programmes in rural Africa: a pro-poor strategy to reach Abuja targets and millennium development goals. BMJ. 328, 1129-1132.
28. Molyneux, D.H. and Zagaria, N. (2002). Lymphatic filariasis elimination: progress in global programme development. Annals of Tropical Medicine and Parasitology. 96 Suppl 2, S15-40.
29. Molyneux, D.H., Hopkins, D.R., and Zagaria, N. (2004). Disease eradication, elimination and control: the need for accurate and consistent usage. Trends in Parasitology. 20, 347-351.
30. Molyneux, D.H., Hotez, P.J., and Fenwick, A. (2005). "Rapid-impact Interventions": How a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. PLoS Medicine, 2: e336.
31. Morel, C.M., Acharya, T., Broun, D., Dangi, A., Elias, C., Ganguly, N.K., Gardner, C.A., Gupta, R.K., Haycock, J., Heher, A.D., Keusch, G.T., Hotez, P.J., Krattiger, A.F., Kreutz, F.T., Lall, S., Lee, K., Mahoney, R., Martinez-Palomo, A., Mashelkar, R.A., Matlin, S., Min, H.K., Mzimba, M., Oehler, J., Pick, W., Ridley, R.G., Senanayake, P., Singer, P., and Yun, M.Y. (2005). Health innovation: the neglected capacity of developing countries to address neglected diseases. Science. 309, 401-404.
32. Murray, C.J.L. (1996). Rethinking DALYs. In: The Global Burden of Disease (Murray, C.J.L. and Lopez, A.D., eds.), Global Burden of Disease and Injury Series, Harvard School of Public Health on behalf of the WHO and World Bank, Harvard University Press.
33. Ostrer, B.S. (2002). Leprosy: medical views of Leviticus Rabba. Early Science and Medicine. 7, 138-154.
34. Pecoul, B., Chirac, P., Trouiller, P., and Pond, J. (1999). Access to essential drugs in poor countries: a lost battle? Journal of the American Medical Association. 281, 361-367.
35. Ramaiah, K.D., Das, P.K., Michael, E., and Guyatt, H. (2000). The economic burden of lymphatic filariasis in India. Parasitol Today. 16, 251-253.
36. Widdus, R. and White, K. (2004). Combating Diseases Associated with Poverty, Financing Strategies for Product Development and the Potential Role of Public-Private-Partnerships, The Initiative on Public-Private-Partnerships for Health (IPPH), pp. 1-10.
37. World Health Organization. (2003). Communicable diseases 2002: global defence against the infectious disease threat (ed. Kindhauser, M.K.), Geneva, pp. 106-107.